CLASS ACTION UPDATE for LCI, OPK, MCHP and CPB: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders


NEW YORK, Oct. 19, 2018 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided. There is no cost or obligation to you.

Lannett Company, Inc. (NYSE: LCI)
Class Period:
February 7, 2018 - August 17, 2018
Lead Plaintiff Deadline: October 26, 2018
Join the action: http://www.zlk.com/pslra-1/lannett-company-inc-loss-form?wire=3

About the lawsuit: Throughout the class period, Lannett Company, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) Lannett faced a substantial risk of the loss of its exclusivity agreement with Jerome Stevens Pharmaceuticals; (2) accordingly, Lannett’s reported revenues were unsustainable; and (3) as a result, Lannett’s public statements were materially false and misleading at all relevant times.

To learn more about the Lannett Company, Inc. class action contact jlevi@levikorsinsky.com.

OPKO Health Inc. (NASDAQ: OPK)
Class Period:
September 26, 2013 - September 7, 2018
Lead Plaintiff Deadline: November 13, 2018
Join the action: https://www.zlk.com/pslra-1/opko-health-inc-loss-form?wire=3

About the lawsuit: During the class period, OPKO Health Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) OPKO and its Chairman and Chief Executive Officer, Phillip Frost, were engaged in a pump-and-dump scheme with several other individuals and companies in their investments in several penny stocks; (2) this illicit scheme would result in governmental scrutiny including from the SEC; and (3) as a result, defendants’ statements about OPKO’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

To learn more about the OPKO Health Inc. class action contact jlevi@levikorsinsky.com.

Microchip Technology Inc. (NASDAQGS: MCHP)
Class Period:
March 2, 2018 - August 9, 2018
Lead Plaintiff Deadline: November 16, 2018
Join the action: https://www.zlk.com/pslra-1/microchip-technology-inc-loss-form?wire=3

About the lawsuit: Throughout the class period, Microchip Technology Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) Microsemi’s financial performance was underperforming Microchip’s expectations; and (2) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, including positive statements about Microsemi, were materially misleading and/or lacked a reasonable basis.

To learn more about the Microchip Technology Inc. class action contact jlevi@levikorsinsky.com.

Campbell Soup Company (NYSE: CPB)
Class Period:
August 31, 2017 - May 17, 2018
Lead Plaintiff Deadline: November 27, 2018
Join the action: https://www.zlk.com/pslra-1/campbell-soup-company-loss-form?wire=3

About the lawsuit: Campbell Soup Company allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) the defendants failed to disclose known trends that were negatively impacting the profitability of the Campbell Fresh division; and (2) as a result of the foregoing, the defendants' positive statements about Campbell's and the Campbell Fresh division's business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.

To learn more about the Campbell Soup Company class action contact jlevi@levikorsinsky.com.

You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com